Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FDXR |
| Upstream (Parents) |
|---|
| (<<) LY6E → FDXR |
| (<<) NUDT6 → FDXR |
| (<<) BTD → FDXR |
| (<<) HHLA3 → FDXR |
| Downstream (Children) |
|---|
| FDXR → SHROOM2 (>>) |
| FDXR → ATP5D (>>) |
| FDXR → PIR (>>) |
| FDXR → KRI1 (>>) |
| FDXR → MAB21L2 (>>) |
| FDXR → SAG (>>) |
| FDXR → NUDT6 (>>) |
| FDXR → DDX51 (>>) |
| FDXR → ARSA (>>) |
| FDXR → TXK (>>) |
| FDXR → INPP5B (>>) |
| FDXR → HHLA3 (>>) |
| FDXR → MYL5 (>>) |
| FDXR → NACAP1 (>>) |
| FDXR → LOC100132247///NPIPL3 (>>) |
| FDXR → SMAD4 (>>) |
